COMMUNIQUÉS West-GlobeNewswire
-
Harrow Announces Add-On Offering of $50.0 Million of Senior Unsecured Notes to Support Growth
24/03/2026 -
IMUNON to Hold 2025 Financial Results and Business Update Conference Call on Tuesday, March 31, 2026
24/03/2026 -
ENvue Medical Expands Presence within a Major Michigan Health System and Grows U.S. Hospital Footprint to 39
24/03/2026 -
SurvivorRx Expands Personalized Supplement Routines as Oncologists Raise Concerns About Supplement Safety for Cancer Survivors
24/03/2026 -
Enzon Announces Reverse Stock Split
24/03/2026 -
ADARx Pharmaceuticals Expands Leadership Team with Appointment of Healthcare Investment Banking Veteran Ryan Fisk as Chief Financial Officer and Chief Business Officer
24/03/2026 -
Lace-Up Ankle Brace Support Gets Comfort Upgrade and Removable Side Stabilizers
24/03/2026 -
SK pharmteco and Prozomix Announce Strategic Collaboration to Enhance Biocatalysis Capabilities for Global Drug Manufacturing
24/03/2026 -
VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs
24/03/2026 -
Costa Rica Achieves Historic First With Nation’s Inaugural Export of GACP-Certified Medical Cannabis to the European Union
24/03/2026 -
Propanc Biopharma Executes Multi-Yr, Anti-Aging & Cancer Research Collaboration with the Universities of Jaén and Granada, Spain
24/03/2026 -
Arch Biopartners and the Fraser Health Authority enter into a Clinical Trial Agreement for the Phase II Cardiac Surgery-Associated AKI Trial
24/03/2026 -
Adial Pharmaceuticals Commends Congress on Introduction of Bipartisan Legislation Expanding Access to Emerging AUD Therapies for Veterans
24/03/2026 -
San Juan Regional Medical Center Selects Full PerfectServe Platform for Enterprise Communication and Scheduling Overhaul
24/03/2026 -
BioAge Labs Reports Full Year 2025 Financial Results and Provides Business Updates from the Fourth Quarter of 2025
24/03/2026 -
Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion
24/03/2026 -
Immutrin raises £65 million ($87 million) Series A to develop next generation antibody therapy for ATTR amyloidosis
24/03/2026 -
Press Release Biocartis NV: Biocartis to Collaborate with Medical College of Wisconsin on Breast Cancer Gene Signatures
24/03/2026 -
Polyrizon Intends to Acquire up to 20% Stake in Colugo, Developer of Advanced eVTOL Drones for Defense and Urban Air Mobility Applications
24/03/2026
Pages